NDAINTRAVENOUSPOWDER
Approved
Dec 2016
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
20
Mechanism of Action
Pharmacologic Class:
Tetracycline-class Antibacterial
Clinical Trials (5)
A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection
Started Nov 2012
470 enrolled
Intra-abdominal Infection
Pharmacokinetics Of Tigecycline In Morbidly Obese Subjects
Started Mar 2012
12 enrolled
Obesity
Study Evaluating Tigecycline Versus Clindamycin Or Vancomycin On Complicated Skin And Skin Structure Infections Including Those Due To Methicillin-Resistant Staphylococcus Aureus (MRSA) In Pediatric Subjects
Started Aug 2011
0Skin DiseasesInfection
Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD)
Started Jul 2011
10 enrolled
DiarrheaClostridium Difficile
Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia
Started Jan 2011
0Community Acquired Bacterial PneumoniaComplicated Intra-Abdominal Infection